Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?

Copy For Citation

Eskazan A. E., Soysal T., Erbilgin Y., Ozbek U., Ferhanoglu B.

LEUKEMIA RESEARCH, vol.35, no.9, 2011 (SCI-Expanded)

• Publication Type: Article / Letter
• Volume: 35 Issue: 9
• Publication Date: 2011
• Doi Number: 10.1016/j.leukres.2011.04.025
• Journal Name: LEUKEMIA RESEARCH
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Istanbul University Affiliated: Yes